Recipharm’s solid dose facility in Fontaine, France has been approved for supply of manufactured products to the Japanese pharmaceuticals market following a recent inspection by the Japanese drug agency, PMDA. The Fontaine site, acquired in 2009 from Solvay Pharma (now Abbott), is also approved to supply to the U.S. and has a distribution center for delivery to pharmacy level in France.   Stéphane Guisado, general manager of the Fontaine site, said, “We are very pleased to have secured this appr...